Discovery of XRF-1021, a 2,4-disubstituted-5-fluoropyrimidine derivative as a homeodomain-interacting protein kinase 2 inhibitor for the treatment of chronic kidney disease
Xinlan Hu(Central South University), Qianbin Li(Central South University), Yan Wu(Shanghai Public Health Clinical Center), Hanyi Ouyang(Central South University), Li Gong(Central South University), Songkai Wang(Central South University), Ling Huang(Southern University of Science and Technology), Yuanyuan Han(Western University), Zhangzhe Peng(Central South University), Jiawei Cheng(Central South University), Yuanyuan Cao(Chinese Academy of Sciences), Qiongjing Yuan(Central South University), Zhuo Chen(Northeast Agricultural University), Yan Zhang(East China University of Science and Technology), Lijian Tao(Central South University), Jianhua Zeng(Shanghai East Hospital), Jie Meng(Central South University), Songsen Fu(Hunan University), Yiwei Xiong(Central South University), Sijue Zou(Central South University), Xin He(Central South University)
Cited by 1
Related Papers
Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery
|Journal of Controlled Release|2005|308
Lectin-conjugated PEG–PLA nanoparticles: Preparation and brain delivery after intranasal administration
|Biomaterials|2006|292
Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase
|Journal of Biological Chemistry|2000|267
Effective thermal conductivity of polymer composites: Theoretical models and simulation models
|International Journal of Heat and Mass Transfer|2017|237